nutrients-logo

Journal Browser

Journal Browser

Bioactive Compounds of Nutraceuticals and Functional Foods for Healthy Brain Ageing: From Bench to Diet

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Neuro Sciences".

Deadline for manuscript submissions: 15 September 2026 | Viewed by 745

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Biochemistry, Medical University of Lodz, 6/8 Mazowiecka Str., 92-215 Lodz, Poland
Interests: brain ageing; brain neoplasms; neurodegenerative diseases; neuroprotection; neuroinflammation; cellular senescence; postbiotics; bioactive compounds in diet

E-Mail Website
Guest Editor
Department of Nucleic Acid Biochemistry, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland
Interests: bioactive peptides; therapeutic peptides; food-derived peptides; neuroprotection; anti-inflammatory activity; anti-aging peptides; neuroplasticity; neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Healthy brain aging is increasingly challenged by chronic, oxidative, and inflammatory processes, referred to as “oxy‑inflamm‑aging”.

These mechanisms contribute to neuronal damage, impaired synaptic plasticity, cognitive decline, and increased risk of neurodegenerative diseases. Growing evidence indicates that bioactive compounds present in nutraceuticals and functional foods can beneficially modulate oxidative stress, systemic and neuro‑inflammation, and key molecular pathways essential for maintaining brain plasticity and resilience.

This Special Issue invites original research and comprehensive reviews that advance our understanding of how diet‑derived molecules may counteract oxy‑inflamm‑aging, prevent cytotoxic exo- and endogenous insults, support neuronal health, and promote cognitive longevity.

We are particularly interested in translational studies that highlight compounds targeting molecular and cellular processes contributing to brain ageing, providing a background for developing evidence-based dietary products for improved health outcomes.

We are looking for investigations focusing on substances beneficial for the following:

- The prophylaxis and supportive management of age‑related CNS disorders, including neurodegenerative diseases and brain malignancies;

- Mitigating accelerated brain ageing and cognitive dysfunction resulting from treatment‑related side effects (e.g., oncotherapy);

- Preventing molecular and cellular damage in CNS cells induced by external stressors, such as environmental, dietary, or therapy‑related stressors, that contribute to brain ageing;

- Enhancing neuroplasticity and cognitive function throughout the ageing process.

Dr. Monika Witusik-Perkowska
Dr. Renata Perlikowska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain ageing
  • neuroprotection
  • oxidative stress and chronic neuroinflammation
  • cellular senescence
  • autophagy and protein turnover
  • age-related DNA alterations and epigenetic modification
  • mitochondrial dysfunction
  • blood–brain barrier functionality
  • neurodegenerative diseases
  • gut–brain axis
  • nutritional neuroscience
  • phytochemicals and bioactive compounds of natural origin
  • translational nutrition

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

18 pages, 6878 KB  
Systematic Review
Animal Studies on the Effects of Edible Bird’s Nest on Cognitive Function and Neuroprotection: A Systematic Review
by Jiaying Chi, Yu Shan Tan, Hemaniswarri Dewi Dewadas, Chai Nien Foo and Yang Mooi Lim
Nutrients 2026, 18(9), 1373; https://doi.org/10.3390/nu18091373 - 27 Apr 2026
Viewed by 545
Abstract
Objectives: This systematic review aims to evaluate the effects of Edible Bird’s Nest (EBN) extract on cognitive function and neuroprotection in animal models and systematically review the relevant research evidence. Methods: A systematic search was conducted in the databases of PubMed, Scopus, Web [...] Read more.
Objectives: This systematic review aims to evaluate the effects of Edible Bird’s Nest (EBN) extract on cognitive function and neuroprotection in animal models and systematically review the relevant research evidence. Methods: A systematic search was conducted in the databases of PubMed, Scopus, Web of Science, EMBASE, Taylor Francis, Wiley, and Cochrane Library for relevant research published up to October 2025. Search terms included “Edible Bird’s Nest”, “Bird’s Nest Extract”, “EBN”, “Swiftlet nest”, “Collocalia”, “Cognitive”, “Memory”, “Learning”, “Neuroprotection”, “Brain”, “Neural”, “Neurotrophic”, “Animal”, “Mice”, “Mouse”, “Rat”, “Rats”, “In vivo”, and “Model”. Two researchers independently screened all the relevant articles, extracted relevant data, and assessed the quality of included studies using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk of bias assessment tool. Results: This systematic review included 11 animal studies, primarily focused on rodent models. Preclinical evidence suggests that Edible Bird’s Nest extract (EBN) may improve performance in several cognitive function tests. Animals treated with EBN appeared to show enhanced spatial memory and learning abilities in experimental settings. At the molecular level, the EBN treatment group showed improved antioxidant capacity and reduced neuroinflammation. Additionally, EBN promoted the expression of neuroprotective factors and enhanced synaptic plasticity. Research suggests that appropriate doses of EBN may have beneficial effects on cognitive enhancement and can alleviate cognitive dysfunction and neuropathological changes. Conclusions: Preliminary evidence from this systematic review suggests that EBN appears to show protective and potentially enhancing effects on cognitive function in animal models. EBN works through multiple mechanisms, including antioxidant and anti-inflammatory effects, as well as promoting the expression of neurotrophic factors and synaptic plasticity. These findings provide initial support for further investigation of EBN as a potential neuroprotective agent and cognitive enhancer. However, there is heterogeneity and methodological limitations in the research, and more standardized studies and preclinical translational research are needed to further validate the application potential of EBN in neuroprotection. These results provide an important reference for developing EBN-based functional foods and supplements for the prevention and adjuvant treatment of cognitive impairment and neurodegenerative diseases. Full article
Show Figures

Figure 1

Back to TopTop